Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Palisade Bio, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 96 | 1 | 124 | +29 |
| Shares | 149.5M | 10.7M | 173.4M | +34.6M (+24.9%) |
| Value | $261.7M | $18.8M | $362.4M | +$119.4M (+49.2%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (50)
Institutions that held Palisade Bio, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (21)
Institutions that held Palisade Bio, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Commodore Capital LP | 7,181,062 | $12.6M |
| Exome Asset Management LLC | 600,000 | $1.05M |
| Jane Street Group, LLC | 410,761 | $718.8K |
| Brevan Howard Capital Management LP | 214,821 | $375.9K |
| HRT Financial LP | 211,882 | $370.0K |
| Qube Research & Technologies Ltd | 148,970 | $260.7K |
| Prelude Capital Management, LLC | 133,131 | $233.0K |
| Graham Capital Management, L.P. | 105,832 | $185.2K |
| Hudson Bay Capital Management LP | 89,386 | $156.4K |
| Omers Administration Corp | 83,300 | $145.8K |
| Diametric Capital, LP | 51,874 | $90.8K |
| Vontobel Holding Ltd. | 45,000 | $78.8K |
| Jefferies Financial Group Inc. | 34,875 | $61.0K |
| Schonfeld Strategic Advisors LLC | 33,146 | $58.0K |
| Catalyst Funds Management Pty Ltd | 31,400 | $55.0K |
| CTC Alternative Strategies, Ltd. | 17,441 | $30.5K |
| Commonwealth Equity Services, LLC | 16,500 | $28.9K |
| LMR Partners LLP | 15,400 | $26.9K |
| Jump Financial, LLC | 15,346 | $26.9K |
| Caitong International Asset Management Co., Ltd | 12,177 | $21.3K |
| RFG Advisory, LLC | 11,750 | $20.6K |
Not filed for Q2 2026 yet (1)
Institutions that held Palisade Bio, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 10,689,452 | $18.8M |